BR100 Increased By (0.52%)
BR30 Increased By (0.49%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.58%)
BECO 5.67 Decreased By ▼ -0.06 (-1.05%)
BML 57.03 Decreased By ▼ -0.27 (-0.47%)
BOP 36.90 Increased By ▲ 0.13 (0.35%)
CNERGY 8.32 Decreased By ▼ -0.07 (-0.83%)
DCL 11.93 Decreased By ▼ -0.11 (-0.91%)
FCCL 58.70 Increased By ▲ 0.09 (0.15%)
FCSC 5.10 Increased By ▲ 0.09 (1.8%)
FFL 18.08 Increased By ▲ 0.14 (0.78%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.31 Decreased By ▼ -0.11 (-0.96%)
KEL 8.26 Decreased By ▼ -0.03 (-0.36%)
KOSM 6.57 Decreased By ▼ -0.05 (-0.76%)
MLCF 107.69 Decreased By ▼ -0.60 (-0.55%)
NBP 209.48 Increased By ▲ 3.44 (1.67%)
PACE 11.20 Increased By ▲ 0.03 (0.27%)
PAEL 45.54 Increased By ▲ 0.19 (0.42%)
PIAHCLA 30.33 Decreased By ▼ -0.44 (-1.43%)
PIBTL 18.87 Decreased By ▼ -0.19 (-1%)
PPL 248.61 Increased By ▲ 2.66 (1.08%)
PRL 36.30 Increased By ▲ 0.22 (0.61%)
PTC 73.75 Increased By ▲ 1.39 (1.92%)
SEARL 96.28 Decreased By ▼ -0.39 (-0.4%)
SSGC 31.43 Decreased By ▼ -0.24 (-0.76%)
TELE 9.23 Decreased By ▼ -0.04 (-0.43%)
THCCL 68.20 Increased By ▲ 0.39 (0.58%)
TPLP 11.60 Increased By ▲ 0.37 (3.29%)
TREET 25.78 Decreased By ▼ -0.11 (-0.42%)
TRG 67.40 Decreased By ▼ -0.44 (-0.65%)
WAVES 11.24 Increased By ▲ 0.26 (2.37%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
By

BEIJING: China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic.

High hopes hang on the small vials of liquid on show at a Beijing trade fair this week -- vaccine candidates produced by Chinese companies Sinovac Biotech and Sinopharm.

Neither has hit the market yet but the makers hope they will be approved after all-important phase 3 trials as early as year-end.

A Sinovac representative told AFP his firm has already "completed the construction of a vaccine factory" able to produce 300 million doses a year.

On Monday, people at the trade fair crowded around booths showing the potential game-changing vaccines.

China, which is facing a storm of foreign criticism over its early handling of the pandemic, has been trying to repurpose the story of Covid-19.

State media and officials are now emphasising the revival of Wuhan, the central Chinese city where the deadly pathogen surfaced, as a success story in the fight against the virus.

Comments

Comments are closed for this article.